The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patent claim landscape of FDA Orange Book–listed oral oncology drugs: A systematic analysis of standard practice claims.
 
Waqas Haque
No Relationships to Disclose
 
Eman Haque
No Relationships to Disclose
 
Sarah Ghalayini
No Relationships to Disclose
 
Murtaza Ahmed
No Relationships to Disclose
 
Iemaan Rana
No Relationships to Disclose
 
Mark Ratain
Stock and Other Ownership Interests - SAB Biotherapeutics
Consulting or Advisory Role - Apotex; Argentum Medical; Astellas Pharma; Cerona Therapeutics; EQRx; Halozyme; Nestle USA; Oscotec; Revolution Medicines; T3 Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Provisional patent application for method of treating viral pneumonitis with low-dose tocilizumab (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - Multiple generic companies (defendants in patent litigation)
Other Relationship - Laura and John Arnold Foundation (Inst); Optimal Cancer Care Alliance (OCCA)